{
 "drug": "Neostigmine Methylsulfate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/12/2026",
 "dayN": 225,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/12/2026",
   "update_type": "New",
   "initial_posting_date": "01/12/2026",
   "package_ndc": "63323-413-10",
   "generic_name": "Neostigmine Methylsulfate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA203629"
    ],
    "brand_name": [
     "NEOSTIGMINE METHYLSULFATE"
    ],
    "generic_name": [
     "NEOSTIGMINE METHYLSULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-413",
     "63323-415"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "NEOSTIGMINE METHYLSULFATE"
    ],
    "rxcui": [
     "311935",
     "311936"
    ],
    "spl_id": [
     "3abc0611-0e8c-49f9-9678-e4b2fda3d8ed",
     "1efedce1-b2c3-4652-a289-6ea596b039e2"
    ],
    "spl_set_id": [
     "6448229c-e650-47ba-bb00-cba3604502c5",
     "d0e11e4c-41c3-4874-b567-579db655fba3"
    ],
    "package_ndc": [
     "63323-413-01",
     "63323-413-10",
     "63323-415-01",
     "63323-415-10",
     "63323-413-36",
     "63323-415-36"
    ],
    "unii": [
     "98IMH7M386"
    ]
   },
   "update_date": "01/12/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}